Survival outcomes of double- and triple-sequential targeted therapy in patients with metastatic renal cell carcinoma: a retrospective comparison

OBJECTIVE: To evaluate the progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) treated with double- and triple-sequence targeted therapy (TT) using tyrosine kinase inhibitors (TKIs) and mammalian target of rapamycin inhibitors (mTORi). MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung Han, Suh, Yoon Seok, Kim, Jung Kwon, Joung, Jae Young, Seo, Ho Kyung, Lee, Kang Hyun, Chung, Jinsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725002/
https://www.ncbi.nlm.nih.gov/pubmed/29245960
http://dx.doi.org/10.18632/oncotarget.21926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725002/
https://www.ncbi.nlm.nih.gov/pubmed/29245960
http://dx.doi.org/10.18632/oncotarget.21926

Ejemplares similares